Answers are grounded in this paper and cite their sources.
Brain cancer is linked to severe neurological and psychosocial disability, having significant impact on health-related quality of life (HRQoL). Nevertheless, current evidence is disjointed because of heterogeneity of study designs, populations, and measurement tools and lacks a consistent global estimate. The study aims to estimate pooled global and domain-specific mean scores of HRQoL among patients with brain cancer and to examine variation across geographic regions, age groups, and measurement instruments. Published studies from January 2000 to January 2025 were obtained through a systematic search of PubMed, Scopus, Web of Science, and Google Scholar. Observational studies reporting quantitative HRQoL outcomes in adults (≥ 18 years) with brain cancer using validated instruments were included. Two independent reviewers selected the studies and extracted the data. The Percentage of Maximum Possible (POMP) method was used to standardize HRQoL mean scores. Random-effects meta-analysis, subgroup analyses, and meta-regression were conducted in this study. A total of 23 studies consisting of 2,163 participants were included in the study. Pooled mean HRQoL scores for global quality of life and functional domains, including physical, emotional, cognitive, social, role and functional. The pooled mean global HRQoL score was 63.19 (95% CI: 60.42–65.96; 95% PI: 50.46–75.91), with substantial between-study heterogeneity (I² = 93.73%). Domain-specific pooled mean scores were 78.01 (95% CI: 74.00–82.03) for physical functioning, 70.07 (95% CI: 66.01–74.12) for emotional functioning, 70.34 (95% CI: 66.71–73.97) for cognitive functioning, 69.11 (95% CI: 63.77–74.45) for social functioning, 70.31 (95% CI: 64.62–76.00) for role functioning, and 64.28 (95% CI: 57.44–71.10) for functional well-being. Subgroup analyses showed that Asian populations had lower HRQoL compared to Europe and America, and younger cohorts had lower scores. The type of instruments had an impact on estimates with higher scores observed in studies using FACT-Br than EORTC QLQ-C30. Meta-regression analysis demonstrated that geographic region was a significant moderator, whereas instrument type and age group were not statistically significant moderators. The findings indicate substantial variation in reported HRQoL among adults with brain cancer across populations and clinical settings. These findings should be interpreted cautiously given the very high between-study heterogeneity and differences in HRQoL measurement instruments.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: